What is the evidence for using hemostatic agents in surgery?

European Spine Journal

Volumn 13, Issue SUPPL. 1, 2004, Pages

  Erstad, Brian L ^a  

^a Division of Plant Pathology and Microbiology   (United States)

Author keywords

Antifibrinolytic agents; Hemorrhage; Hemostatics

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; DESMOPRESSIN; HEMOSTATIC AGENT; PLACEBO; PROTON PUMP INHIBITOR; TRANEXAMIC ACID;

BLEEDING; BLOOD AUTOTRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEMATOCRIT; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SPINE SURGERY; THROMBOEMBOLISM;

APROTININ; BLOOD LOSS, SURGICAL; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; RANDOMIZED CONTROLLED TRIALS; SPINE; TREATMENT OUTCOME;

EID: 8444250725     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-004-0717-1     Document Type: Review

References (38)

1. Auvinen O, Baer GA, Nordback I, Saaristo J (1987) Antifibrinolytic therapy for prevention of hemorrhage during surgery of the thyroid gland. Klin Wochenschr 65:253-255
2. Benoni G, Fredin H. (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty. J Bone Joint Surg (Br) 78-B:434-440
3. Bennett-Guerrero E, Sorohan JG, Gurevich ML, Kazanjian PE, Levy RR, Barberá AV, et al (1997) Cost-benefit and efficacy of aprotinin compared with ε-aminocaproic acid in patients having repeated cardiac operations: A randomized blinded clinical trial. Anesthesiology 87:1373-1380
4. Bennett-Guerrero E, Spillane WEF, White WD, Muhlbaier LH, Gall SA, Smith PK, et al (1999) Epsilon-aminocaproic acid adminstration and stroke following coronary artery bypass graft surgery. Ann Thorac Surg 67:1283-1287
5. Berenholz SM, Pronovost PJ, Mullany D, Garrett E, Ness PM, Dorman T, Klag MJ (2002) Predictors of transfusion for spinal surgery in Maryland, 1997 to 2000. Transfusion 42:183-189
6. Cha CW, Deible C, Muzzonigro T, Lopez-Plaza I, Vogt M, Kang JD (2002) Allogeneic transfusion requirements after autologous donations in posterior lumbar surgeries. Spine 27: 99-104
7. Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al (2000) Tranexamic acid reduces red cell transfusion better than ε-aminocaproic acid or placebo in liver transplantation. Anesth Analg 91:29-34
8. Dietrich W, Späth P, Zühlsdorf M, Dalichau H, Kirchhoff PG, Kuppe H, et al (2001) Anaphylactic reactions to aprotinin reexposure in cardiac surgery. Anesthesiology 95:64-71
9. Erstad BL (2001) Antifibrinolytic agents and desmopressin as hemostatic agents in cardiac surgery. Ann Pharmacother 35:1075-1084
10. Florentino-Pineda I, Blakemore LC, Thompson GH, Poe-Kochert C, Adler P, Tripi P (2001) The effect of ε-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion. Spine 26:1147-1151
11. Garcia-Huete L, Domenech P, Sabate A, Martínez-Brotons F, Jaurrieta E, Figueras J (1997) The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study. Hepatology 26:1143-1148
12. Hedlund PO (1969) Antifibrinolytic therapy with Cyklokapron in connection with prostatectomy. Scand J Urol Nephrol 3:177-182
13. Henry DA, Moxey AJ, Carless PA, O'Connell D, McClelland B, Henderson KM, et al (2003) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews, 3
14. Hiippala ST, Strid LJ, Wennerstrand MI, Arvela VV, Niemela HM, Mantyla SK, et al (1997) Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 84:839-844
15. Jeserschek R, Clar H, Aigner C, Rehak P, Primus B, Windhager R (2003) Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery. J Bone Joint Surg (Br) 85-B:174-177
16. Karnezis TA., Stulberg SD, Wixson RL, Reilly P (1994) The hemostatic effects of desmopressin on patients who had total joint arthroplasty. J Bone Joint Surg 76A(10):1545-1550
17. Kovesi T, Royston D (2003) Pharmacological approaches to reducing allogeneic blood exposure. Vos Sanguinis 84:2-10
18. Lawrence ACK, Ward-McQuad JN (1996) The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy. Br J Urol 38:308-310
19. Lelorier J, Gregoire G, Benhaddad A, LaPierrre J, Derderian F (1997) Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337:535-542
20. Lentschener C, Benhamou D, Mercier FJ, Boyer-Neumann C, Naveau S, Smadja C, et al (1997) Aprotinin reduced blood loss in patients undergoing elective liver resection. Anesth Analg 84:875-881
21. Lentschener C, Cottin P, Bouaziz H, Mercier FJ, Wolf M, Aljabi Y, et al (1999) Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg 89:590-597
22. Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, et al (1995) A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 82:2236-2244
23. Miller RA, May MW, Hendry WF, Whitfield HN, Wickham JEA (1980) The prevention of secondary haemorrhage after prostatectomy: the value of antifibrinolytic therapy. Br J Urol 52: 26-28
24. Murkin JM, Haig GM, Beer KJ, Cicutti N, McCutchen J, Comunale ME, et al (2000) Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg 82-A(5):675-684
25. Naeye RL (1962) Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood 19:694-701
26. Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93:82-87
27. Nuttall GA, Horlocker TT, Santrach PJ, Oliver WC, Dekutoski MB, Bryant S (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 25:596-601
28. Porte RJ, Molenaar IQ, Begliomini B, Groenland THN, Januszkiewicz A, Lindgren L, et al (2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. Lancet 355:1303-1309
29. Press release: $4 million nationwide study aims to prevent life-threatening blood loss in heart surgery patients. Canadian Institutes of Health Research. http://www.cihr-irsc.gc.ca/e/news/8013.shtml, pp 1-4. cited Feb 3, 2004
30. Samama CM, Langeron O, Rosencher N, Capdevila X, Rouche P, Pegoix M, et al (2002) Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study. Anesth Analg 95:287-293
31. Schött U, Sollén C, Axelsson K, Rugarn P, Allvin I (1995) Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesth Scand 39:592-598
32. Schünemann HJ, Best D, Vist G, Oxman AD, for the GRADED Working Group (2003) Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ 169:677-680
33. Smith RB, Riach P, Kaufman JJ (1984) Epsilon aminocaproic acid and the control of post-prostatectomy bleeding: a prospective double-blind study. J Urology 131:1093-1095
34. Upshur REG (2003) Are all evidence-based practices alike? Problems in the ranking of evidence. CMAJ 169:672-673
35. Urban MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O (2001) The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 26:1152-1157
36. Vinnicombe J, Shuttleworth KED (1966) Aminocaproic acid in the control of haemorrhage after prostatectomy. Lancet 1:230-232
37. Wymenga LFA, Van Der Boon, WJV (1998) Obstruction of the renal pelvis due to an insoluble blood clot after epsilon-aminocaproic acid therapy: resolution with intraureteral streptokinase instillations. J Urol 159:490-492
38. Zheng F, Cammisa FP, Sandhu HS, Girardi FP, Khan SN (2002) Factors predicting hospital stay, operative time, blood loss, and transfusion in patients undergoing revision posterior lumbar spine decompression, fusion, and segmental instrumentation. Spine 27:818-824